Delivery Order 75N92024D00012-75N92024F00002
- Not listed
- This is a $6,734,645.00 delivery order contract awarded by the National Heart Lung and Blood Institute (NHLBI), a civilian agency, to The Regents of the University of California, San Francisco (UCSF) for the "SUBPOPULATIONS AND INTERMEDIATE OUTCOMES IN COPD (SPIROMICS) III - TASK AREA A - YEAR 1" effort. The contract has an ultimate completion date of June 17, 2026 and does not have a set-aside designation. UCSF is a prominent academic medical center and research institution that has a...
- The National Heart Lung and Blood Institute issued a delivery order to The Regents of the University of California, San Francisco on July 25, 2025, for the SPIROMICS III respiratory disease research project, with a ceiling value of $7,037,497 and an ultimate completion date of July 24, 2027. This is a cost-no-fee delivery order issued without a set-aside. Place of performance is San Francisco, CA. The order supports biomedical research on subpopulations and intermediate outcomes in COPD (Chronic...
- This is a federal contract award from the National Heart Lung and Blood Institute, a civilian agency, to National Jewish Health, a non-profit hospital and research center located in Denver, Colorado. The contract has a ceiling value of $9,292,344.00 and is a Delivery Order contract type with a cost-no-fee pricing structure. The contract is for "COPD GENE - GENETIC EPIDEMIOLOGY OF COPD - TASK AREA A: YEAR 3" and has an ultimate completion date of August 9, 2026. This contract is not set...
- The National Heart, Lung, and Blood Institute (NHLBI), a civilian agency within the National Institutes of Health, awarded a definitive contract to the Regents of the University of California for applied and exploratory biomedical research. The contract, valued at $1.13M on a cost, no-fee basis, was awarded on April 15, 2003, with an ultimate completion date of September 29, 2011. The work is being performed in San Francisco, California, and no small business set-aside was utilized for this...
- The National Heart Lung and Blood Institute (NHLBI) of the National Institutes of Health awarded a $8,193,539.00 Delivery Order contract to National Jewish Health, a non-profit respiratory hospital and research center in Denver, Colorado. The contract is for Task A of the Genetic Epidemiology of COPD (COPDGene) study, which involves collecting study data and biospecimens and providing oversight for the COPDGene study. This award is part of a larger NHLBI single-award Indefinite Delivery...
- This is a $1,809,248.54 cost-type definitive contract awarded by the National Heart Lung and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH), to The Regents of the University of California, San Francisco (UCSF) for the "Prevention of Anastomotic Intimal Hyperplasia by a Pro-Resolving Perivascular Device" research project. The contract supports the development and testing of a medical device designed to prevent a cardiovascular condition called...
- This federal contract award, with an ID of HHSN268201200031C, was issued by the National Heart, Lung, and Blood Institute (NHLBI), a civilian agency, to The Regents of the University of California, San Francisco (UCSF) for the Osteoarthritis Initiative Data Coordinating Center. The definitive, cost-no-fee contract has a ceiling value of $8,811,628.18 and a completion date of October 31, 2017. It does not have a set-aside designation. Under this contract, UCSF will coordinate the Osteoarthritis...
- This is a $3,250,000.00 definitive contract awarded by the National Heart Lung and Blood Institute (NHLBI), part of the National Institutes of Health (NIH), to Trustees of Boston University (Boston University) to build and support a critical national biorepository of normal and lung disease-specific induced pluripotent stem cells (iPSCs) and their differentiated progeny. This contract supports the NHLBI's efforts to establish a sustainable resource to serve the lung research community. The...
- This is a federal contract award to the University of California, San Diego (UCSD) by the National Heart, Lung, and Blood Institute (NHLBI), a civilian agency, for a biomedical research project. The contract has a ceiling value of $801,574.00 and was awarded on December 13, 1996 with a period of performance through December 31, 2006. The contract does not have a set-aside designation. UCSD is a public research university that has previously received federal contract awards from agencies like the...
- This federal contract award was issued by the National Heart Lung and Blood Institute (NHLBI), a civilian agency within the U.S. Department of Health and Human Services, to the University of California, Davis (UC Davis) for $83,747. The award is a firm fixed-price purchase order with an ultimate completion date of August 31, 2018. The contract does not carry a small business set-aside designation. UC Davis, a major public land-grant research university, frequently receives federal awards to...
- 75N92024D00012Indefinite Delivery Contract
- 75N92024D00012-75N92024F00002Delivery Order
This is a $1,185,983 federal contract awarded by the National Heart Lung and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH), to the University of California, San Francisco (UCSF) to conduct the SUBPOPULATIONS AND INTERMEDIATE OUTCOMES IN COPD (SPIROMICS) III - TASK AREA B research initiative. The contract is a delivery order with a cost-no-fee pricing type and has an ultimate completion date of June 17, 2031. This contract is a task order under a larger $49,722,874 single-award Indefinite Delivery Contract (IDC) that UCSF holds with NHLBI for the SPIROMICS III study, which focuses on chronic obstructive pulmonary disease (COPD) research. The contract does not have a set-aside designation, reflecting UCSF's status as a large, established institution. This award leverages UCSF's expertise in pulmonary medicine and clinical research to support the NHLBI's efforts to advance scientific understanding and improve public health outcomes related to COPD.
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
Subpopulations and Intermediate Outcomes in COPD (SPIROMICS) III | 75N92023R0203 | Department of Health and Human Services National Institutes of Health National Heart Lung and Blood Institute | Pre-Solicitation 1/2 | 7/25/23, 11:28 AM | |
SubPopulations and InteRmediate Outcomes in COPD ( | 75N92023R0203 | Department of Health and Human Services National Institutes of Health National Heart Lung and Blood Institute | Award Notice 2/2 | 7/17/24, 9:56 AM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00001 | Funding Only Action | ($206k) | 5/2/25 | |
| Not listed | Not listed | $206.4k | 6/18/24 |